GW Pharmaceuticals - Additional Listing

* Reuters is not responsible for the content in this press release.

Thu Apr 17, 2008 12:19pm EDT 

RNS Number:6054S
GW Pharmaceuticals PLC
17 April 2008



                    GW PHARMACEUTICALS PLC ("the Company")

Application has been made to the London Stock Exchange for admission to trading
on AIM in respect of a block listing of 300,000 ordinary shares of 0.1p each
("New Ordinary Shares").

The New Ordinary Shares will be issued from time to time pursuant to the
exercise of employee share options under the Company's Executive Share Option
Scheme 2001.  On exercise the shares will be issued credited as fully paid and
will rank pari passu with the existing ordinary shares in issue.

It is expected that such admission will become effective on 23 April 2008.


For further information, please contact:

Adam George, GW Pharmaceuticals plc

Telephone: 01980 557000


                      This information is provided by RNS
            The company news service from the London Stock Exchange

END

LISBLGDSBUBGGIR
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.